pathwayName,pathwayId,pathwaySource,Pval,Num_In_Path,Total_In_Path,Pval_FDR,Pval_Holm,analytes,,,,,
Histidine metabolism,map00340,kegg,0.999610249,2,35,1,1,Glutamate; L-Glutamic acid;Histidine; L-Histidine,,,,,
beta-Alanine metabolism,map00410,kegg,0.993380986,3,29,1,1,Glutamate; L-Glutamic acid;Histidine; L-Histidine;Pantothenic acid,,,,,
"Glycine, serine and threonine metabolism",map00260,kegg,0.999497789,6,56,1,1,Creatine;Glycine;Guanidoacetic acid;Glutamate; L-Glutamic acid;L-Serine; Serine;Ornithine,,,,,
Methionine Metabolism,map00270,kegg,0.999982406,3,51,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Tyrosine metabolism,map00350,kegg,0.999862599,2,69,1,1,Glutamate; L-Glutamic acid;L-Tyrosine,,,,,
Starch and sucrose metabolism,map00500,kegg,0.999999918,3,53,1,1,"L-Serine; Serine;SM(d18:1/18:0); Sphingomyelin;PC(14:0_20:0); PC(20:0/18:2(9Z,12Z))",,,,,
Arginine and proline metabolism,map00330,kegg,0.999870183,7,50,1,1,Creatine;Glycine;Guanidoacetic acid;Glutamate; L-Glutamic acid;L-Proline;Ornithine;Citrulline,,,,,
Phenylalanine and Tyrosine Metabolism,map00360,kegg,0.994229527,2,28,1,1,Glutamate; L-Glutamic acid;L-Tyrosine,,,,,
Tryptophan metabolism,map00380,kegg,0.999894668,2,54,1,1,Glutamate; L-Glutamic acid;Indoleacetic acid,,,,,
"Alanine, aspartate and glutamate metabolism",map00250,kegg,0.999964299,4,60,1,1,Glycine;Glutamate; L-Glutamic acid;L-Asparagine;Citrulline,,,,,
Nitrogen metabolism,map00910,kegg,0.699400327,5,25,1,1,Glycine;Glutamate; L-Glutamic acid;L-Asparagine;Histidine; L-Histidine;L-Serine; Serine,,,,,
Purine metabolism,map00230,kegg,1,3,68,1,1,Glycine;Glutamate; L-Glutamic acid;Uric acid,,,,,
Primary bile acid biosynthesis,map00120,kegg,0.924051497,5,60,1,1,"Glycine;Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;Taurodeoxycholate; Taurodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA;CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Amino Sugar Metabolism,map00520,kegg,0.999993414,2,35,1,1,Glutamate; L-Glutamic acid;bGalNAc; N-Acetyl-b-D-galactosamine,,,,,
Glutathione metabolism,map00480,kegg,0.999998873,2,18,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Phospholipid Biosynthesis,map00564,kegg,0.999999969,3,25,1,1,"DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);PC(14:0_20:0); PC(20:0/18:2(9Z,12Z));1-hexadecanoyl-sn-glycero-3-phosphocholine; LPC(14:1); LysoPC(16:0/0:0);LPC(14:1); LysoPC(16:1(9Z)/0:0);LPC(14:1); LysoPC(18:3(6Z,9Z,12Z)/0:0);LPC(14:1); LysoPC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0);LPC(14:1); LysoPC(24:0/0:0)",,,,,
Arachidonic Acid Metabolism,map00590,kegg,0.999999668,2,64,1,1,Glutamate; L-Glutamic acid;LPC(14:0); LysoPC(14:0/0:0),,,,,
Caffeine Metabolism,map00232,kegg,0.752430673,2,19,1,1,Theophylline;5-Acetylamino-6-amino-3-methyluracil,,,,,
Metabolism of fat-soluble vitamins,R-HSA-6806667,reactome,0.999594215,3,46,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Arachidonic acid metabolism,R-HSA-2142753,reactome,0.999998873,2,110,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
G alpha (i) signalling events,R-HSA-418594,reactome,1,2,109,1,1,"Glutamate; L-Glutamic acid;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Class C/3 (Metabotropic glutamate/pheromone receptors),R-HSA-420499,reactome,0.999351633,2,57,1,1,Glutamate; L-Glutamic acid;Ornithine,,,,,
"Transport of bile salts and organic acids, metal ions and amine compounds",R-HSA-425366,reactome,0.999999752,9,78,1,1,Glycine;L-Tyrosine;L-Proline;L-Asparagine;Histidine; L-Histidine;L-Serine; Serine;Uric acid;4-Hydroxyproline; hydroxy-proline;Dehydroepiandrosterone sulfate; DHEA-SO4; ST 19:1;O2;S,,,,,
Organic cation/anion/zwitterion transport,R-HSA-549132,reactome,0.972155993,2,34,1,1,Uric acid;Dehydroepiandrosterone sulfate; DHEA-SO4; ST 19:1;O2;S,,,,,
Organic anion transport,R-HSA-561048,reactome,0.651110258,2,8,1,1,Uric acid;Dehydroepiandrosterone sulfate; DHEA-SO4; ST 19:1;O2;S,,,,,
Metabolism of water-soluble vitamins and cofactors,R-HSA-196849,reactome,1,5,133,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine;Pantothenic acid;Thiamine; THMN,,,,,
Cellular responses to stress,R-HSA-2262752,reactome,0.995366228,2,90,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Cellular responses to stimuli,R-HSA-8953897,reactome,0.995366228,2,92,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Glycerophospholipid biosynthesis,R-HSA-1483206,reactome,1,2,102,1,1,"L-Serine; Serine;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))",,,,,
Phospholipid metabolism,R-HSA-1483257,reactome,1,2,112,1,1,"L-Serine; Serine;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))",,,,,
Hemostasis,R-HSA-109582,reactome,0.926911065,3,83,1,1,"Citrulline;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Neurotransmitter receptors and postsynaptic signal transmission,R-HSA-112314,reactome,1,3,25,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Transmission across Chemical Synapses,R-HSA-112315,reactome,1,3,78,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Neuronal System,R-HSA-112316,reactome,1,3,78,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Binding and Uptake of Ligands by Scavenger Receptors,R-HSA-2173782,reactome,0.998929633,3,41,1,1,"bGalNAc; N-Acetyl-b-D-galactosamine;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Scavenging by Class B Receptors,R-HSA-3000471,reactome,0.589589731,2,16,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Scavenging by Class A Receptors,R-HSA-3000480,reactome,0.949365755,3,32,1,1,"bGalNAc; N-Acetyl-b-D-galactosamine;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Scavenging by Class H Receptors,R-HSA-3000497,reactome,0.520651836,2,11,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Vesicle-mediated transport,R-HSA-5653656,reactome,0.990843933,3,66,1,1,"bGalNAc; N-Acetyl-b-D-galactosamine;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Signaling by Receptor Tyrosine Kinases,R-HSA-9006934,reactome,0.998743622,3,64,1,1,"Citrulline;ADMA; Symmetric dimethylarginine;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Metabolism of folate and pterines,R-HSA-196757,reactome,0.895455505,3,26,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Glyoxylate metabolism and glycine degradation,R-HSA-389661,reactome,0.99916634,2,40,1,1,Glycine;4-Hydroxyproline; hydroxy-proline,,,,,
Metabolic disorders of biological oxidation enzymes,R-HSA-5579029,reactome,0.999610249,2,51,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Biosynthesis of specialized proresolving mediators (SPMs),R-HSA-9018678,reactome,0.977596631,2,116,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Selenoamino acid metabolism,R-HSA-2408522,reactome,1,3,68,1,1,Glycine;L-Serine; Serine;bGalNAc; N-Acetyl-b-D-galactosamine,,,,,
ROS and RNS production in phagocytes,R-HSA-1222556,reactome,0.999496786,2,48,1,1,bGalNAc; N-Acetyl-b-D-galactosamine;Citrulline,,,,,
Innate Immune System,R-HSA-168249,reactome,0.994008053,5,128,1,1,"bGalNAc; N-Acetyl-b-D-galactosamine;Citrulline;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Biosynthesis of DHA-derived SPMs,R-HSA-9018677,reactome,0.947415607,2,57,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Biosynthesis of DHA-derived sulfido conjugates,R-HSA-9026395,reactome,0.444692488,2,22,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Biosynthesis of maresin conjugates in tissue regeneration (MCTR),R-HSA-9026762,reactome,0.444692488,2,9,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Phase II - Conjugation of compounds,R-HSA-156580,reactome,1,4,149,1,1,Glycine;Glutamate; L-Glutamic acid;Pregnenolone sulfate; PREGS;Dehydroepiandrosterone sulfate; DHEA-SO4; ST 19:1;O2;S,,,,,
Drug ADME,R-HSA-9748784,reactome,1,2,115,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Paracetamol ADME,R-HSA-9753281,reactome,0.997161119,2,31,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Cytosolic sulfonation of small molecules,R-HSA-156584,reactome,0.992722894,2,47,1,1,Pregnenolone sulfate; PREGS;Dehydroepiandrosterone sulfate; DHEA-SO4; ST 19:1;O2;S,,,,,
Glutathione conjugation,R-HSA-156590,reactome,0.999496786,2,30,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR),R-HSA-9026766,reactome,0.362793463,2,18,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Tyrosine catabolism,R-HSA-8963684,reactome,0.70527381,2,14,1,1,Glutamate; L-Glutamic acid;L-Tyrosine,,,,,
Phenylalanine and tyrosine metabolism,R-HSA-8963691,reactome,0.957337338,2,31,1,1,Glutamate; L-Glutamic acid;L-Tyrosine,,,,,
SLC transporter disorders,R-HSA-5619102,reactome,0.999999997,8,81,1,1,Glycine;Glutamate; L-Glutamic acid;L-Tyrosine;L-Proline;Histidine; L-Histidine;L-Serine; Serine;L-Cystine;Uric acid,,,,,
Disorders of transmembrane transporters,R-HSA-5619115,reactome,1,10,99,1,1,"Glycine;Glutamate; L-Glutamic acid;L-Tyrosine;L-Proline;Histidine; L-Histidine;L-Serine; Serine;L-Cystine;Uric acid;Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA",,,,,
Purine ribonucleoside monophosphate biosynthesis,R-HSA-73817,reactome,0.920840385,2,37,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Nucleotide biosynthesis,R-HSA-8956320,reactome,0.965486385,2,48,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Degradation of cysteine and homocysteine,R-HSA-1614558,reactome,0.972155993,2,38,1,1,Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Sulfur amino acid metabolism,R-HSA-1614635,reactome,0.999610249,2,66,1,1,Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Carnitine synthesis,R-HSA-71262,reactome,0.520651836,2,17,1,1,"Glycine;N6,N6,N6-Trimethyl-L-lysine; TMLYS",,,,,
RAF/MAP kinase cascade,R-HSA-5673001,reactome,0.98101357,4,46,1,1,"Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
MAPK family signaling cascades,R-HSA-5683057,reactome,0.947415607,4,46,1,1,"Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
MAPK1/MAPK3 signaling,R-HSA-5684996,reactome,0.947415607,4,46,1,1,"Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Platelet homeostasis,R-HSA-418346,reactome,0.999999997,3,36,1,1,"Citrulline;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
ESR-mediated signaling,R-HSA-8939211,reactome,1,2,35,1,1,Citrulline;ADMA; Symmetric dimethylarginine,,,,,
Signaling by Nuclear Receptors,R-HSA-9006931,reactome,0.998743622,2,53,1,1,Citrulline;ADMA; Symmetric dimethylarginine,,,,,
G alpha (q) signalling events,R-HSA-416476,reactome,1,2,63,1,1,Glutamate; L-Glutamic acid;Ornithine,,,,,
"Metabolism of ingested SeMet, Sec, MeSec into H2Se",R-HSA-2408508,reactome,0.935380604,2,33,1,1,Glycine;L-Serine; Serine,,,,,
Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393,reactome,0.999999348,11,53,1,1,Glycine;Glutamate; L-Glutamic acid;L-Tyrosine;L-Proline;L-Asparagine;Histidine; L-Histidine;L-Serine; Serine;L-Cystine;Ornithine;Homo-L-arginine; homoArg;4-Hydroxyproline; hydroxy-proline,,,,,
Tryptophan catabolism,R-HSA-71240,reactome,0.923780515,4,35,1,1,Glutamate; L-Glutamic acid;L-Tyrosine;Histidine; L-Histidine;Indolelactic acid,,,,,
Glutamate and glutamine metabolism,R-HSA-8964539,reactome,0.912308976,3,25,1,1,Glutamate; L-Glutamic acid;L-Proline;Ornithine,,,,,
Serine biosynthesis,R-HSA-977347,reactome,0.827896813,2,15,1,1,Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Aflatoxin activation and detoxification,R-HSA-5423646,reactome,0.957337338,2,30,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Aspartate and asparagine metabolism,R-HSA-8963693,reactome,0.935380604,2,24,1,1,Glutamate; L-Glutamic acid;L-Asparagine,,,,,
Developmental Biology,R-HSA-1266738,reactome,0.755908786,5,40,1,1,"Glycine;Glutamate; L-Glutamic acid;13-HODE; Coriolic acid;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Visual phototransduction,R-HSA-2187338,reactome,1,3,66,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Retinoid metabolism and transport,R-HSA-975634,reactome,0.998929633,3,35,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Signaling by VEGF,R-HSA-194138,reactome,1,3,29,1,1,"Citrulline;ADMA; Symmetric dimethylarginine;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Metabolism of nitric oxide: NOS3 activation and regulation,R-HSA-202131,reactome,0.965486385,2,26,1,1,Citrulline;ADMA; Symmetric dimethylarginine,,,,,
eNOS activation,R-HSA-203615,reactome,0.920840385,2,26,1,1,Citrulline;ADMA; Symmetric dimethylarginine,,,,,
VEGFA-VEGFR2 Pathway,R-HSA-4420097,reactome,1,3,29,1,1,"Citrulline;ADMA; Symmetric dimethylarginine;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
VEGFR2 mediated vascular permeability,R-HSA-5218920,reactome,0.990843933,2,17,1,1,Citrulline;ADMA; Symmetric dimethylarginine,,,,,
Triglyceride metabolism,R-HSA-8979227,reactome,0.99916634,2,28,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Extra-nuclear estrogen signaling,R-HSA-9009391,reactome,0.999999987,2,28,1,1,Citrulline;ADMA; Symmetric dimethylarginine,,,,,
Recycling of bile acids and salts,R-HSA-159418,reactome,0.949365755,3,20,1,1,"Glycine;Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA",,,,,
Triglyceride catabolism,R-HSA-163560,reactome,0.988506747,2,18,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Sphingolipid de novo biosynthesis,R-HSA-1660661,reactome,0.999337783,3,38,1,1,"L-Serine; Serine;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);ceramide phosphocholine  (sphingomyelin, SM); N-lauroyl-D-erythro-Sphingosylphosphoryl choline; SM(d18:1/20:0)",,,,,
Glycosphingolipid metabolism,R-HSA-1660662,reactome,0.999594215,3,38,1,1,"bGalNAc; N-Acetyl-b-D-galactosamine;Dehydroepiandrosterone sulfate; DHEA-SO4; ST 19:1;O2;S;ceramide phosphocholine  (sphingomyelin, SM); N-lauroyl-D-erythro-Sphingosylphosphoryl choline; SM(d18:1/20:0)",,,,,
Toll-like Receptor Cascades,R-HSA-168898,reactome,1,2,36,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Glutathione synthesis and recycling,R-HSA-174403,reactome,0.903348799,2,13,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
"Plasma lipoprotein assembly, remodeling, and clearance",R-HSA-174824,reactome,0.999999013,3,20,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Synthesis of bile acids and bile salts,R-HSA-192105,reactome,0.998929633,3,73,1,1,"Glycine;Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA",,,,,
Digestion of dietary lipid,R-HSA-192456,reactome,0.401742186,5,17,1,1,"Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,R-HSA-193368,reactome,0.989827398,3,49,1,1,"Glycine;Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA",,,,,
Bile acid and bile salt metabolism,R-HSA-194068,reactome,0.999753707,3,74,1,1,"Glycine;Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA",,,,,
Membrane Trafficking,R-HSA-199991,reactome,0.690389565,2,31,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Synthesis of Leukotrienes (LT) and Eoxins (EX),R-HSA-2142691,reactome,0.965486385,2,30,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
EPH-Ephrin signaling,R-HSA-2682334,reactome,1,2,10,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Cytosolic tRNA aminoacylation,R-HSA-379716,reactome,0.929570864,7,66,1,1,Glycine;Glutamate; L-Glutamic acid;L-Tyrosine;L-Proline;L-Asparagine;Histidine; L-Histidine;L-Serine; Serine,,,,,
tRNA Aminoacylation,R-HSA-379724,reactome,0.996992359,7,66,1,1,Glycine;Glutamate; L-Glutamic acid;L-Tyrosine;L-Proline;L-Asparagine;Histidine; L-Histidine;L-Serine; Serine,,,,,
Mitochondrial tRNA aminoacylation,R-HSA-379726,reactome,0.918651472,7,66,1,1,Glycine;Glutamate; L-Glutamic acid;L-Tyrosine;L-Proline;L-Asparagine;Histidine; L-Histidine;L-Serine; Serine,,,,,
EPHB-mediated forward signaling,R-HSA-3928662,reactome,0.999894668,2,10,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Axon guidance,R-HSA-422475,reactome,0.807778169,3,20,1,1,"Glycine;Glutamate; L-Glutamic acid;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Sphingolipid metabolism,R-HSA-428157,reactome,0.999999803,5,68,1,1,"L-Serine; Serine;bGalNAc; N-Acetyl-b-D-galactosamine;Dehydroepiandrosterone sulfate; DHEA-SO4; ST 19:1;O2;S;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);ceramide phosphocholine  (sphingomyelin, SM); N-lauroyl-D-erythro-Sphingosylphosphoryl choline; SM(d18:1/20:0)",,,,,
Activation of NMDA receptors and postsynaptic events,R-HSA-442755,reactome,0.999999994,3,18,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
ABC transporter disorders,R-HSA-5619084,reactome,0.999999991,2,22,1,1,"Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA",,,,,
Defective ABCB11 causes PFIC2 and BRIC2,R-HSA-5678520,reactome,0.520651836,2,6,1,1,"Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA",,,,,
Keratinization,R-HSA-6805567,reactome,1,2,11,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Formation of the cornified envelope,R-HSA-6809371,reactome,1,2,11,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Urea cycle,R-HSA-70635,reactome,0.827065578,3,22,1,1,Glutamate; L-Glutamic acid;Ornithine;Citrulline,,,,,
Proline catabolism,R-HSA-70688,reactome,0.216814446,3,11,1,1,Glutamate; L-Glutamic acid;L-Proline;4-Hydroxyproline; hydroxy-proline,,,,,
Histidine catabolism,R-HSA-70921,reactome,0.857453866,2,22,1,1,Glutamate; L-Glutamic acid;Histidine; L-Histidine,,,,,
Creatine metabolism,R-HSA-71288,reactome,0.628285194,4,15,1,1,Creatine;Glycine;Guanidoacetic acid;Ornithine,,,,,
Translation,R-HSA-72766,reactome,1,7,83,1,1,Glycine;Glutamate; L-Glutamic acid;L-Tyrosine;L-Proline;L-Asparagine;Histidine; L-Histidine;L-Serine; Serine,,,,,
Clathrin-mediated endocytosis,R-HSA-8856828,reactome,1,2,17,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Digestion,R-HSA-8935690,reactome,0.896763201,5,43,1,1,"Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Carboxyterminal post-translational modifications of tubulin,R-HSA-8955332,reactome,0.99864412,3,10,1,1,Glycine;Glutamate; L-Glutamic acid;L-Tyrosine,,,,,
Digestion and absorption,R-HSA-8963743,reactome,0.935211258,5,45,1,1,"Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Assembly of active LPL and LIPC lipase complexes,R-HSA-8963889,reactome,0.947415607,2,6,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Plasma lipoprotein assembly,R-HSA-8963898,reactome,0.972155993,2,11,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Plasma lipoprotein remodeling,R-HSA-8963899,reactome,0.99178335,3,15,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
LDL clearance,R-HSA-8964038,reactome,0.957337338,2,9,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Plasma lipoprotein clearance,R-HSA-8964043,reactome,0.99863036,2,9,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
HDL remodeling,R-HSA-8964058,reactome,0.635775967,3,12,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Intracellular signaling by second messengers,R-HSA-9006925,reactome,0.999568557,2,27,1,1,"13-HODE; Coriolic acid;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Negative regulation of NMDA receptor-mediated neuronal transmission,R-HSA-9617324,reactome,0.938980717,3,6,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
LTC4-CYSLTR mediated IL4 production,R-HSA-9664535,reactome,0.589589731,2,7,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Nervous system development,R-HSA-9675108,reactome,0.938980717,3,20,1,1,"Glycine;Glutamate; L-Glutamic acid;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Amino acid transport across the plasma membrane,R-HSA-352230,reactome,0.839471488,11,32,1,1,Glycine;Glutamate; L-Glutamic acid;L-Tyrosine;L-Proline;L-Asparagine;Histidine; L-Histidine;L-Serine; Serine;L-Cystine;Ornithine;Homo-L-arginine; homoArg;4-Hydroxyproline; hydroxy-proline,,,,,
Miscellaneous transport and binding events,R-HSA-5223345,reactome,0.988506747,2,11,1,1,Histidine; L-Histidine;L-Cystine,,,,,
"Transport of vitamins, nucleosides, and related molecules",R-HSA-425397,reactome,0.99989868,4,62,1,1,"Pantothenic acid;Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA;Dehydroepiandrosterone sulfate; DHEA-SO4; ST 19:1;O2;S",,,,,
Transport of organic anions,R-HSA-879518,reactome,0.682798551,3,16,1,1,"Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA;Dehydroepiandrosterone sulfate; DHEA-SO4; ST 19:1;O2;S",,,,,
Heme signaling,R-HSA-9707616,reactome,0.999988339,2,18,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Chylomicron remodeling,R-HSA-8963901,reactome,0.635775967,3,7,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Cell surface interactions at the vascular wall,R-HSA-202733,reactome,1,2,13,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Scavenging by Class F Receptors,R-HSA-3000484,reactome,0.589589731,2,9,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Platelet sensitization by LDL,R-HSA-432142,reactome,0.965486385,2,6,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Regulation of TLR by endogenous ligand,R-HSA-5686938,reactome,0.957337338,2,16,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Cargo recognition for clathrin-mediated endocytosis,R-HSA-8856825,reactome,1,2,10,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Post NMDA receptor activation events,R-HSA-438064,reactome,0.999999845,3,13,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
"Unblocking of NMDA receptors, glutamate binding and activation",R-HSA-438066,reactome,0.912308976,3,7,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,R-HSA-442742,reactome,0.987440141,3,10,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Ras activation upon Ca2+ influx through NMDA receptor,R-HSA-442982,reactome,0.938980717,3,6,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Long-term potentiation,R-HSA-9620244,reactome,0.949365755,3,6,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Na+/Cl- dependent neurotransmitter transporters,R-HSA-442660,reactome,0.877271159,7,32,1,1,Glycine;L-Tyrosine;L-Proline;L-Asparagine;Histidine; L-Histidine;L-Serine; Serine;4-Hydroxyproline; hydroxy-proline,,,,,
Variant SLC6A14 may confer susceptibility towards obesity,R-HSA-5619094,reactome,0.635775967,3,15,1,1,Glycine;Histidine; L-Histidine;L-Serine; Serine,,,,,
Amino acid metabolism pathway excerpt: histidine catabolism extension,WP4661,wiki,0.903348799,2,17,1,1,Glutamate; L-Glutamic acid;Histidine; L-Histidine,,,,,
Cysteine and methionine catabolism,WP4504,wiki,0.923780515,4,39,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine;L-Cystine,,,,,
Methionine de novo and salvage pathway,WP3580,wiki,0.99824997,2,49,1,1,Glutamate; L-Glutamic acid;Ornithine,,,,,
Extra-nuclear estrogen signaling,WP4977,wiki,0.999999982,2,27,1,1,Citrulline;ADMA; Symmetric dimethylarginine,,,,,
Metabolism of water-soluble vitamins and cofactors,WP1857,wiki,0.999999997,2,82,1,1,Pantothenic acid;Thiamine; THMN,,,,,
Vitamin B6-dependent and responsive disorders,WP4228,wiki,0.827896813,2,20,1,1,Glutamate; L-Glutamic acid;L-Proline,,,,,
Serine metabolism,WP4688,wiki,0.725323324,3,25,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Aflatoxin activation and detoxification,WP3306,wiki,0.957337338,2,28,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Clathrin-mediated endocytosis,WP4065,wiki,1,2,15,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Sulfur amino acid metabolism,WP3574,wiki,0.999496786,2,69,1,1,Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Amino acid metabolism in triple-negative breast cancer cells,WP5213,wiki,0.725323324,3,19,1,1,Glutamate; L-Glutamic acid;L-Serine; Serine;L-Cystine,,,,,
Purine metabolism and related disorders,WP4224,wiki,0.997161119,2,58,1,1,Glutamate; L-Glutamic acid;Uric acid,,,,,
Anti-inflammatory response favouring Leishmania parasite infection,WP4993,wiki,1,3,35,1,1,"Glycine;Glutamate; L-Glutamic acid;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
RAF/MAP kinase cascade,WP2735,wiki,0.98101357,3,15,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
EPH-Ephrin signaling,WP3309,wiki,1,2,9,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Miscellaneous transport and binding events,WP3320,wiki,0.985607415,2,10,1,1,Histidine; L-Histidine;L-Cystine,,,,,
Kennedy pathway from sphingolipids,WP3933,wiki,0.935380604,2,20,1,1,"L-Serine; Serine;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Serine biosynthesis,WP4435,wiki,0.827896813,2,16,1,1,Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Lipid metabolism pathway,WP3965,wiki,0.997161119,2,13,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
16p11.2 proximal deletion syndrome,WP4949,wiki,0.999999974,2,40,1,1,"DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);1-hexadecanoyl-sn-glycero-3-phosphocholine; LPC(14:1); LysoPC(16:0/0:0);LPC(14:1); LysoPC(16:1(9Z)/0:0);LPC(14:1); LysoPC(18:3(6Z,9Z,12Z)/0:0);LPC(14:1); LysoPC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0);LPC(14:1); LysoPC(24:0/0:0)",,,,,
Vitamin D-sensitive calcium signaling in depression,WP4698,wiki,0.995434544,2,15,1,1,"Glutamate; L-Glutamic acid;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Ferroptosis,WP4313,wiki,0.999998209,3,40,1,1,Glutamate; L-Glutamic acid;L-Cystine;LPE(18:0); LysoPE; LysoPE(18:0/0:0),,,,,
Metabolic reprogramming in pancreatic cancer,WP5220,wiki,0.999919419,2,31,1,1,"Glutamate; L-Glutamic acid;CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Keratinization,WP4087,wiki,0.999999974,2,9,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Digestion,WP4104,wiki,0.880310362,5,40,1,1,"Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Amino acid metabolism,WP3925,wiki,0.999999636,12,109,1,1,Glycine;Guanidoacetic acid;Glutamate; L-Glutamic acid;L-Tyrosine;L-Proline;L-Asparagine;Histidine; L-Histidine;L-Serine; Serine;Indoleacetic acid;Ornithine;4-Hydroxyproline; hydroxy-proline;Citrulline,,,,,
Arachidonic acid metabolism,WP2650,wiki,0.999894668,2,70,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Cholesterol metabolism,WP5304,wiki,0.999987938,4,32,1,1,"Glutamate; L-Glutamic acid;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
tRNA aminoacylation,WP1938,wiki,0.996992359,7,26,1,1,Glycine;Glutamate; L-Glutamic acid;L-Tyrosine;L-Proline;L-Asparagine;Histidine; L-Histidine;L-Serine; Serine,,,,,
Bile acid and bile salt metabolism,WP1788,wiki,0.999753707,3,75,1,1,"Glycine;Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA",,,,,
Signaling by VEGF,WP1919,wiki,1,3,28,1,1,"Citrulline;ADMA; Symmetric dimethylarginine;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Glycine metabolism,WP1495,wiki,0.378564998,4,13,1,1,Creatine;Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Binding and uptake of ligands by scavenger receptors,WP2784,wiki,0.998929633,3,35,1,1,"bGalNAc; N-Acetyl-b-D-galactosamine;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
"Leucine, isoleucine and valine metabolism",WP4686,wiki,0.99824997,2,68,1,1,CAR 5:0; Isovalerylcarnitine;O-Propanoylcarnitine; Propionylcarnitine; PROPIONYLCARNITINE (C3),,,,,
Biomarkers for urea cycle disorders,WP4583,wiki,0.62260035,6,22,1,1,Creatine;Guanidoacetic acid;Glutamate; L-Glutamic acid;L-Tyrosine;Ornithine;Citrulline,,,,,
Urea cycle and metabolism of amino groups,WP497,wiki,0.747233675,7,34,1,1,Creatine;Guanidoacetic acid;Glutamate; L-Glutamic acid;L-Proline;Ornithine;Citrulline;N2-Acetyl-L-ornithine; N2-Acetylornithine,,,,,
Amino acid transport defects (IEMs),WP5029,wiki,0.262060896,8,27,1,1,Glycine;Glutamate; L-Glutamic acid;L-Tyrosine;L-Proline;L-Asparagine;Histidine; L-Histidine;L-Serine; Serine;L-Cystine,,,,,
Creatine pathway,WP5190,wiki,0.307565408,5,18,1,1,Creatine;Glycine;Guanidoacetic acid;Glutamate; L-Glutamic acid;L-Proline,,,,,
Fatty Acids and Lipoproteins Transport in Hepatocytes,WP5323,wiki,0.947415607,2,7,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Lipid particles composition,WP3601,wiki,0.752430673,2,10,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Nucleobase biosynthesis,WP4084,wiki,0.972155993,2,47,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Tryptophan catabolism,WP4994,wiki,0.923780515,4,34,1,1,Glutamate; L-Glutamic acid;L-Tyrosine;Histidine; L-Histidine;Indolelactic acid,,,,,
Proximal tubule transport,WP4917,wiki,0.999851924,3,25,1,1,Glycine;L-Proline;L-Cystine,,,,,
Glutathione metabolism,WP100,wiki,0.977596631,2,21,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Biogenic amine synthesis,WP550,wiki,0.853159169,3,17,1,1,Glutamate; L-Glutamic acid;L-Tyrosine;Histidine; L-Histidine,,,,,
Metabolism of nitric oxide: NOS3 activation and regulation,WP1850,wiki,0.965486385,2,27,1,1,Citrulline;ADMA; Symmetric dimethylarginine,,,,,
HIF1A and PPARG regulation of glycolysis,WP2456,wiki,0.827896813,2,10,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Tryptophan metabolism,WP465,wiki,0.998930324,2,61,1,1,Indoleacetic acid;Indolelactic acid,,,,,
Metabolic reprogramming in colon cancer,WP4290,wiki,0.995959342,5,38,1,1,Glycine;Glutamate; L-Glutamic acid;L-Proline;L-Asparagine;L-Serine; Serine,,,,,
Neuroinflammation and glutamatergic signaling,WP5083,wiki,1,3,27,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Carnitine synthesis,WP4996,wiki,0.520651836,2,16,1,1,"Glycine;N6,N6,N6-Trimethyl-L-lysine; TMLYS",,,,,
"Transport of bile salts and organic acids, metal ions and amine compounds",WP1935,wiki,0.999999752,9,70,1,1,Glycine;L-Tyrosine;L-Proline;L-Asparagine;Histidine; L-Histidine;L-Serine; Serine;Uric acid;4-Hydroxyproline; hydroxy-proline;Dehydroepiandrosterone sulfate; DHEA-SO4; ST 19:1;O2;S,,,,,
Metabolic pathways of fibroblasts,WP5312,wiki,0.982005218,4,25,1,1,Glycine;Glutamate; L-Glutamic acid;L-Proline;L-Serine; Serine,,,,,
Glycerophospholipid biosynthetic pathway,WP2533,wiki,0.99916634,2,57,1,1,"L-Serine; Serine;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))",,,,,
Enterocyte cholesterol metabolism,WP5333,wiki,0.991888102,4,29,1,1,"Glutamate; L-Glutamic acid;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Thyroid hormones production and peripheral downstream signaling effects,WP4746,wiki,0.999999998,2,25,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Thermogenesis,WP4321,wiki,1,2,26,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway,WP4577,wiki,0.998929633,3,23,1,1,"L-Serine; Serine;Pantothenic acid;ceramide phosphocholine  (sphingomyelin, SM); N-lauroyl-D-erythro-Sphingosylphosphoryl choline; SM(d18:1/20:0)",,,,,
Urea cycle and related diseases,WP4571,wiki,0.763416111,3,14,1,1,Glutamate; L-Glutamic acid;Ornithine;Citrulline,,,,,
Orexin receptor pathway,WP5094,wiki,0.999972963,2,19,1,1,"Glutamate; L-Glutamic acid;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))",,,,,
"Plasma lipoprotein assembly, remodeling, and clearance",WP4129,wiki,0.999998209,3,21,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Selenium micronutrient network,WP15,wiki,1,3,110,1,1,"L-Serine; Serine;Uric acid;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))",,,,,
Triacylglyceride synthesis,WP325,wiki,0.985607415,2,10,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Aspartate and asparagine metabolism,WP4979,wiki,0.935380604,2,25,1,1,Glutamate; L-Glutamic acid;L-Asparagine,,,,,
Urea cycle and associated pathways,WP4595,wiki,0.98518973,4,30,1,1,Glutamate; L-Glutamic acid;L-Proline;Ornithine;Citrulline,,,,,
Sphingolipid metabolism: integrated pathway,WP4726,wiki,0.880310362,5,51,1,1,"L-Serine; Serine;SM(d18:1/18:0); Sphingomyelin;C24 SM; SM(d18:1/24:0);ceramide phosphocholine  (sphingomyelin, SM); N-lauroyl-D-erythro-Sphingosylphosphoryl choline; SM(d18:1/20:0);C22 SM; C22 Sphingomyelin; SM(d18:1/22:0)",,,,,
Carnosine metabolism of glial cells,WP5313,wiki,0.520651836,2,9,1,1,Glutamate; L-Glutamic acid;Histidine; L-Histidine,,,,,
Glucose homeostasis,WP661,wiki,0.461690418,6,21,1,1,"L-Tyrosine;Histidine; L-Histidine;Ornithine;Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;Citrulline;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA",,,,,
Platelet homeostasis,WP1885,wiki,0.999999969,3,28,1,1,"Citrulline;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Pyrimidine metabolism and related diseases,WP4225,wiki,0.98101357,3,43,1,1,Glutamate; L-Glutamic acid;Ornithine;Citrulline,,,,,
Ethanol effects on histone modifications,WP3996,wiki,0.99863036,2,21,1,1,Glycine;L-Serine; Serine,,,,,
Glycerophospholipid biosynthesis,WP2740,wiki,1,2,94,1,1,"L-Serine; Serine;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))",,,,,
One-carbon metabolism,WP241,wiki,0.99824997,2,25,1,1,Glycine;L-Serine; Serine,,,,,
Folate metabolism,WP176,wiki,0.999999013,3,65,1,1,"Glycine;L-Serine; Serine;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))",,,,,
Phase II - Conjugation of compounds,WP4111,wiki,1,4,149,1,1,Glycine;Glutamate; L-Glutamic acid;Pregnenolone sulfate; PREGS;Dehydroepiandrosterone sulfate; DHEA-SO4; ST 19:1;O2;S,,,,,
Phosphatidylcholine catabolism,WP4195,wiki,0.584333773,3,20,1,1,"PC(18:0/20:4(5Z,8Z,11Z,14Z)); PC(18:0/20:4); PC(18:0_20:4);1-hexadecanoyl-sn-glycero-3-phosphocholine; LPC(14:1); LysoPC(16:0/0:0);LPC(14:1); LysoPC(16:1(9Z)/0:0);LPC(14:1); LysoPC(18:3(6Z,9Z,12Z)/0:0);LPC(14:1); LysoPC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0);LPC(14:1); LysoPC(24:0/0:0);ceramide phosphocholine  (sphingomyelin, SM); N-lauroyl-D-erythro-Sphingosylphosphoryl choline; SM(d18:1/20:0)",,,,,
Glyoxylate metabolism,WP5166,wiki,0.763416111,3,15,1,1,Glycine;L-Serine; Serine;4-Hydroxyproline; hydroxy-proline,,,,,
Metabolism overview,WP3602,wiki,0.806633161,4,116,1,1,"Glutamate; L-Glutamic acid;Ornithine;Citrulline;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))",,,,,
"Trans-sulfuration, one-carbon metabolism and related pathways",WP2525,wiki,0.999998321,5,59,1,1,"Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine;Ornithine;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA",,,,,
"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases",WP4518,wiki,0.70527381,2,11,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Sphingolipid metabolism,WP2788,wiki,0.999999803,5,66,1,1,"L-Serine; Serine;bGalNAc; N-Acetyl-b-D-galactosamine;Dehydroepiandrosterone sulfate; DHEA-SO4; ST 19:1;O2;S;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);ceramide phosphocholine  (sphingomyelin, SM); N-lauroyl-D-erythro-Sphingosylphosphoryl choline; SM(d18:1/20:0)",,,,,
Glyoxylate metabolism and glycine degradation,WP3562,wiki,0.99916634,2,40,1,1,Glycine;4-Hydroxyproline; hydroxy-proline,,,,,
Selenoamino acid metabolism,WP3791,wiki,1,3,61,1,1,Glycine;L-Serine; Serine;bGalNAc; N-Acetyl-b-D-galactosamine,,,,,
Retinoid metabolism and transport,WP3839,wiki,0.99178335,3,34,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
22q11.2 copy number variation syndrome,WP4657,wiki,1,3,29,1,1,Glutamate; L-Glutamic acid;L-Proline;Ornithine,,,,,
Regulation of TLR by endogenous ligand,WP4069,wiki,0.920840385,2,12,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Carboxyterminal post-translational modifications of tubulin,WP4075,wiki,0.996593727,3,9,1,1,Glycine;Glutamate; L-Glutamic acid;L-Tyrosine,,,,,
Triglyceride metabolism,WP4131,wiki,0.99916634,2,28,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Proline catabolism,WP5009,wiki,0.216814446,3,11,1,1,Glutamate; L-Glutamic acid;L-Proline;4-Hydroxyproline; hydroxy-proline,,,,,
Vitamin B12 metabolism,WP1533,wiki,0.999972963,2,60,1,1,"L-Serine; Serine;TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))",,,,,
Sphingolipid metabolism in senescence,WP5121,wiki,0.997161119,2,14,1,1,"L-Serine; Serine;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Disorders of folate metabolism and transport,WP4259,wiki,0.949365755,3,29,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
Sphingolipid pathway,WP1422,wiki,0.994229527,2,25,1,1,L-Serine; Serine;SM(d18:1/18:0); Sphingomyelin,,,,,
"mRNA, protein, and metabolite inducation pathway by cyclosporin A",WP3953,wiki,0.903348799,2,13,1,1,L-Tyrosine;L-Asparagine,,,,,
Statin inhibition of cholesterol production,WP430,wiki,0.971630042,3,17,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0);CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
Major receptors targeted by epinephrine and norepinephrine,WP4589,wiki,0.947415607,2,8,1,1,"L-Serine; Serine;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Disorders of bile acid synthesis and biliary transport,WP5176,wiki,0.988506747,2,41,1,1,"Chenodeoxycholic acid glycine conjugate; GCDCA;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA",,,,,
Thyroxine (thyroid hormone) production,WP1981,wiki,0.977596631,2,12,1,1,"L-Tyrosine;DAG; DG(16:0/16:0/0:0); DG(16:0_16:0);DG(16:0/16:1(9Z)/0:0); DG(16:0_16:0);DG(16:0/18:0/0:0); DG(16:0_16:0);DG(16:0/18:2(9Z,12Z)/0:0); DG(16:0_16:0);DG(16:0_16:0); DG(16:1(9Z)/18:2(9Z,12Z)/0:0)",,,,,
Biosynthesis of DHA-derived SPMs,WP4439,wiki,0.947415607,2,57,1,1,Glycine;Glutamate; L-Glutamic acid,,,,,
Phenylalanine and tyrosine metabolism,WP4981,wiki,0.957337338,2,32,1,1,Glutamate; L-Glutamic acid;L-Tyrosine,,,,,
Cell surface interactions at the vascular wall,WP1794,wiki,1,2,11,1,1,"TG(16:0/16:0/16:1(9Z));TG(16:0/16:0/18:1(9Z));TG(16:0/16:0/18:2(9Z,12Z));TG(16:0/18:0/18:1(9Z));TG(16:0/18:0/18:2(9Z,12Z));TG(16:0/16:1(9Z)/18:1(9Z));TG(16:0/18:1(9Z)/18:2(9Z,12Z));TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/16:1(9Z)/18:1(9Z));TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z));TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z));TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z));CE(20:4(5Z,8Z,11Z,14Z));CE(22:4(7Z,10Z,13Z,16Z));CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z));CE(18:0);CE(18:3(9Z,12Z,15Z))",,,,,
MECP2 and associated Rett syndrome,WP3584,wiki,0.999999462,3,11,1,1,Glycine;Glutamate; L-Glutamic acid;L-Serine; Serine,,,,,
"Transport of vitamins, nucleosides, and related molecules",WP1937,wiki,0.999982406,3,65,1,1,"Pantothenic acid;Tauroursodeoxycholic acid;2-[(3a,7a-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate; Taurochenodesoxycholic acid; TCDCA;Dehydroepiandrosterone sulfate; DHEA-SO4; ST 19:1;O2;S",,,,,
NO/cGMP/PKG mediated neuroprotection,WP4008,wiki,0.99995313,2,16,1,1,Glutamate; L-Glutamic acid;Citrulline,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,,,,,,,